Real-time enrollment status for this colon cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 4:48 PM UTC
| NCT Number | NCT05855200 |
| Recruiting Status | Recruiting |
| Condition | Colon Cancer |
| Phase | PHASE3 |
| Target Enrollment | 892 participants |
| Active Locations | 49 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | January 23, 2026 (Jan 23, 2026) |
As of August 28, 2026: Clinical trial NCT05855200 is currently recruiting participants. This phase3 study for colon cancer is actively seeking new participants at 49 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05855200 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 49 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05855200 was last updated Jan 23, 2026 (January 23, 2026). HelloStudys verifies this status automatically.